Iranian Red Crescent Medical Journal

Published by: Kowsar

Prediction of Biomarkers for Hepatocellular Carcinoma Through Microarray-Based DNA Methylation Analysis

Yan-Lan Zhang 1 , Zhong-Yue Han 2 , Xiu Pang 3 and Cheng Xu 4 , *
Authors Information
1 Department of Infectious Disease, People’s Hospital of Rizhao, Rizhao 276826, Shandong PR, China
2 Department of Gynecology, People’s Hospital of Rizhao, Rizhao 276826, Shandong PR, China
3 Digestive System Department, Ji Ning Hospitai of Tranditional Chinese Medicine, Jining 272000, Shandong PR, China
4 Department of Infectious Disease, People’s Hospital of Linyi, Linyi 276000, Shandong PR, China
Article information
  • Iranian Red Crescent Medical Journal: January 2018, 20 (1); e14873
  • Published Online: January 7, 2018
  • Article Type: Research Article
  • Received: June 8, 2017
  • Revised: July 19, 2017
  • Accepted: October 21, 2017
  • DOI: 10.5812/ircmj.14873

To Cite: Zhang Y, Han Z, Pang X, Xu C. Prediction of Biomarkers for Hepatocellular Carcinoma Through Microarray-Based DNA Methylation Analysis, Iran Red Crescent Med J. 2018 ; 20(1):e14873. doi: 10.5812/ircmj.14873.

Abstract
Copyright © 2018, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
5. Conclusion
Acknowledgements
Footnotes
References
  • 1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-76. doi: 10.1053/j.gastro.2007.04.061. [PubMed: 17570226].
  • 2. Wang YC, Wei LJ, Liu JT, Li SX, Wang QS. Comparison of Cancer Incidence between China and the USA. Cancer Biol Med. 2012;9(2):128-32. doi: 10.3969/j.issn.2095-3941.2012.02.009. [PubMed: 23691468].
  • 3. Kudo M. Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol. 2004;39(3):205-14. doi: 10.1007/s00535-003-1280-y. [PubMed: 15064996].
  • 4. Brudvik KW, Vauthey JN. Peeling-off technique or bile duct resection of tumor thrombus in hepatocellular carcinoma: does future liver-directed treatment justify less extensive surgery?. Ann Surg. 2015;261(5). e126. doi: 10.1097/SLA.0000000000001210. [PubMed: 25775077].
  • 5. McCormack L, Petrowsky H, Clavien PA. Surgical therapy of hepatocellular carcinoma. Europ J Gastroenterol Hepatol. 2005;17(5):497-503.
  • 6. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011;140(5):1501-12 e2. doi: 10.1053/j.gastro.2011.02.006. [PubMed: 21320499].
  • 7. Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013;144(5):1024-30. doi: 10.1053/j.gastro.2013.01.021. [PubMed: 23333348].
  • 8. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002;62(10):2890-6. [PubMed: 12019169].
  • 9. Liu F, Zhou D, Zhang Q, Wang B. Comments on the article of Bu, et al entitled "P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis". Int J Clin Exp Pathol. 2015;8(3):3384-5. [PubMed: 26045875].
  • 10. Ganguly A, Shields CL. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis. 2010;16:1292-303. [PubMed: 20664703].
  • 11. Reis AH, Vargas FR, Lemos B. More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma. Front Genet. 2012;3:284. doi: 10.3389/fgene.2012.00284. [PubMed: 23233862].
  • 12. Portales-Casamar E, Lussier AA, Jones MJ, MacIsaac JL, Edgar RD, Mah SM, et al. DNA methylation signature of human fetal alcohol spectrum disorder. Epigenetics Chromatin. 2016;9:25. doi: 10.1186/s13072-016-0074-4. [PubMed: 27358653].
  • 13. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057-68. doi: 10.1038/nbt.1685. [PubMed: 20944598].
  • 14. Zhao Y, Sun J, Zhang H, Guo S, Gu J, Wang W, et al. High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq. Clin Epigenetics. 2014;6(1):18. doi: 10.1186/1868-7083-6-18. [PubMed: 25276247].
  • 15. Jiang F, Todd NW, Li R, Zhang H, Fang H, Stass SA. A panel of sputum-based genomic marker for early detection of lung cancer. Cancer Prev Res (Phila). 2010;3(12):1571-8. doi: 10.1158/1940-6207.CAPR-10-0128. [PubMed: 20864512].
  • 16. Zhu J, Yao X. Use of DNA methylation for cancer detection: promises and challenges. Int J Biochem Cell Biol. 2009;41(1):147-54. doi: 10.1016/j.biocel.2008.09.003. [PubMed: 18834953].
  • 17. Lambert MP. Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factors. Clinic Epigenet. 2015;7(1):15.
  • 18. Yamada N, Yasui K, Dohi O, Gen Y, Tomie A, Kitaichi T, et al. Genome-wide DNA methylation analysis in hepatocellular carcinoma. Oncol Rep. 2016;35(4):2228-36. doi: 10.3892/or.2016.4619. [PubMed: 26883180].
  • 19. Villanueva A, Hoshida Y, Toffanin S, Lachenmayer A, Alsinet C, Savic R, et al. New strategies in hepatocellular carcinoma: genomic prognostic markers. Clin Cancer Res. 2010;16(19):4688-94. doi: 10.1158/1078-0432.CCR-09-1811. [PubMed: 20713493].
  • 20. Mah WC, Thurnherr T, Chow PK, Chung AY, Ooi LL, Toh HC, et al. Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis. PLoS One. 2014;9(8). e104158. doi: 10.1371/journal.pone.0104158. [PubMed: 25093504].
  • 21. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587. doi: 10.1186/1471-2105-11-587. [PubMed: 21118553].
  • 22. Wu P, Farrell WE, Haworth KE, Emes RD, Kitchen MO, Glossop JR, et al. Maternal genome-wide DNA methylation profiling in gestational diabetes shows distinctive disease-associated changes relative to matched healthy pregnancies. Epigenet. 2016;(just-accepted):00.
  • 23. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29(2):189-96. doi: 10.1093/bioinformatics/bts680. [PubMed: 23175756].
  • 24. Fryer AA, Emes RD, Ismail KM, Haworth KE, Mein C, Carroll WD, et al. Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans. Epigenetics. 2011;6(1):86-94. doi: 10.4161/epi.6.1.13392. [PubMed: 20864804].
  • 25. Glossop JR, Nixon NB, Emes RD, Haworth KE, Packham JC, Dawes PT, et al. Epigenome-wide profiling identifies significant differences in DNA methylation between matched-pairs of T- and B-lymphocytes from healthy individuals. Epigenetics. 2013;8(11):1188-97. doi: 10.4161/epi.26265. [PubMed: 24005183].
  • 26. Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, et al. Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Hum Mol Genet. 2009;18(24):4808-17. doi: 10.1093/hmg/ddp445. [PubMed: 19776032].
  • 27. Suzuki R, Shimodaira H. Hierarchical Clustering with p-Values via Multiscale Bootstrap Resampling. R Packag Ver. 2009:1.2-1.
  • 28. Deu-Pons J, Schroeder MP, Lopez-Bigas N. jHeatmap: an interactive heatmap viewer for the web. Bioinformatics. 2014;30(12):1757-8. doi: 10.1093/bioinformatics/btu094. [PubMed: 24567544].
  • 29. Kumatani S, Itoh T, Motohashi Y, Umezu K, Takatsuka M, editors. Time-Varying Data Visualization Using Clustered Heatmap and Dual Scatterplots. Information Visualisation (IV), 2016 20th International Conference. 2016. IEEE; 2016. p. 63-8.
  • 30. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Natur Potocol. 2008;4(1):44.
  • 31. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1-2):279-84.
  • 32. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012;8(2). e1002375. doi: 10.1371/journal.pcbi.1002375. [PubMed: 22383865].
  • 33. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucleic Acid Res. 2007;36(suppl_1):D480-4.
  • 34. Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844-55. doi: 10.1136/gutjnl-2013-306627. [PubMed: 24531850].
  • 35. Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG, Ma L, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One. 2013;8(7). e68193. doi: 10.1371/journal.pone.0068193. [PubMed: 23874536].
  • 36. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406(6797):782-7. doi: 10.1038/35021228. [PubMed: 10963608].
  • 37. Brinkhoff B, Ostroumov D, Heemcke J, Woller N, Gurlevik E, Manns MP, et al. Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancers. Eur J Immunol. 2014;44(4):1213-24. doi: 10.1002/eji.201343794. [PubMed: 24338782].
  • 38. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25(18):2586-93. doi: 10.1200/JCO.2006.09.4565. [PubMed: 17577038].
  • 39. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006;10(2):99-111. doi: 10.1016/j.ccr.2006.06.016. [PubMed: 16904609].
  • 40. Butler JE, Kadonaga JT. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev. 2002;16(20):2583-92. doi: 10.1101/gad.1026202. [PubMed: 12381658].
  • 41. Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F, et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol. 2005;79(9):5548-56.
  • 42. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56(6):1384-91. doi: 10.1016/j.jhep.2011.10.027. [PubMed: 22326465].
  • 43. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene. 2007;26(6):851-8. doi: 10.1038/sj.onc.1209846. [PubMed: 16878148].
  • 44. Watanabe M, Maemura K, Oki K, Shiraishi N, Shibayama Y, Katsu K. Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. Histol Histopathol. 2006;21(10):1135-41. doi: 10.14670/HH-21.1135. [PubMed: 16835836].
  • 45. Urrego D, Tomczak AP, Zahed F, Stuhmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci. 2014;369(1638):20130094. doi: 10.1098/rstb.2013.0094. [PubMed: 24493742].
  • 46. Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int. 2012;32(5):752-60. doi: 10.1111/j.1478-3231.2011.02750.x. [PubMed: 22276989].
  • 47. Mah WC, Lee CG. DNA methylation: potential biomarker in Hepatocellular Carcinoma. Biomark Res. 2014;2(1):5. doi: 10.1186/2050-7771-2-5. [PubMed: 24635883].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments